
|
Norwest Venture Partners (NVP) is a global venture capital firm that has actively partnered with entrepreneurs to build great businesses for more than 45 years. NVP focuses on investments in information technology including: semiconductor and components, enterprise and communication systems, software, services, consumer internet and media. The firm currently manages more than $2.5 billion in venture capital out of its office in Palo Alto, California, USA. NVP has funded over 400 companies since inception. Recent NVP transactions include Airespace (acquired by Cisco Systems), Resonext Communication (acquired by RF Micro Devices), Spinnaker Networks |
(acquired by Network Appliance), and Winphoria Networks (acquired by Motorola).NVP has also funded such market leaders as Actel Corporation,Brocade Communications, Cerent (acquired by Cisco Systems), Documentum, Extreme Networks, Forte Software (acquired by Sun Microsysytems), PeopleSoft and Tivoli Systems (acquired by IBM). Additional information on Norwest Venture Partners is available at www.nvp.com. |
new investment fund of $600 million, InterWest has 11 experienced partners in Menlo Park, CA and Dallas, TX, who bring together deep domain knowledge in life sciences and information technology.
InterWest Partners has consistently helped grow some of the most influential companies in information technology and life sciences. The firm’s investments in information technology include: CIENA (CIEN), Copper Mountain Networks (CMTN), Crystal Semiconductor (acquired by Cirrus Logic, CRUS) Cyrix (CYRX; acquired by National Semiconductor (NSM), Lightera (acquired by CIENA), PlaceWare (acquired by Microsoft, MSFT), SiTera (acquired by Vitesse, VTSS), Silicon Graphics (SGI), Stratacom (STRM; acquired by Cisco, CSCO) and Xilinx (XLNX).
The firm’s investments in life sciences include: ArthroCare (ARTC), Aspreva Pharmaceuticals Corporation (ASPV), Cor Therapeutics (CORR; acquired by Millennium Pharmaceuticals, MLNM), Corixa (CRXA), Coulter Pharmaceutical (CLTR; acquired by Corixa Pharmaceuticals, CRXA), Cubist Pharmaceuticals (CBST). Epicor Medical (acquired by Saint Jude Medical, STJ), Inspire Pharmaceuticals (ISPH), IntraLase (ILSE), Myogen (MYOG), Spinal Dynamics (acquired by Medtronic, MDT), TheraSense (THER; acquired by Abbott Labs, ABT) and Ventritex (VNTX; acquired by Saint Jude Medical, STJ).
Com Venture
Com Ventures (www.comventures.com) is a leading early-stage venture capital firm investing in the companies that are defining the new era of communications from internet and mobile applications down through the underlying infrastructure. With $1.5 billion under management, Com Ventures’ partners have invested in more than 100 companies. Current investments include: Fabrik, MarketTools, Zantaz, Azul, FyreStorm, OpSource and Vyatta. Prior investments include: Broadcom (NASDAQ:BRCM), SiteSmith (acquired by MFN), Arbinet (NASDAQ:ARBX), Chromatis (acquired by Lucent Technologies), P-Cube (acquired by Cisco Systems), Intruvert Networks (acquired by McAfee), Kagoor Networks (acquired by Juniper Networks) and Monterey (acquired by Cisco Systems). Cypress Semiconductor Corporation |
Cypress solutions perform : consumer, computation, data communications, automotive, industrial, and solar. Leveraging proprietary silicon processes, Cypress’s product portfolio includes a broad selection of wired and wireless
USB devices, CMOS image sensors, timing solutions, specialty memories, high-bandwidth synchronous and micropower memory products, optical solutions and reconfigurable mixed-signal arrays. Cypress trades on the NYSE under the ticker symbol CY.
You can find more about Cypress and its legendary President and CEO
T.J. Rodgers at www.cypress.com. |